Rodrigo Dienstmann
Active 2010–2025
- 92
- Papers
- 18,894
- Citations
- 55
- h-index
- 83
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine52.6%
- Biochemistry, Genetics and Molecular Biology39.3%
- Immunology and Microbiology2.5%
- Computer Science1.9%
- Chemistry0.7%
- Neuroscience0.6%
- Other2.4%
Topics
- Cancer Genomics and Diagnostics7.3%
- Colorectal Cancer Treatments and Studies5.8%
- Genetic factors in colorectal cancer5.3%
- Cancer Immunotherapy and Biomarkers4.8%
- Cancer Cells and Metastasis3%
- Lung Cancer Treatments and Mutations2.5%
- Other71.3%
Coauthors
- Josep Tabernero36
- Paolo Nucíforo21
- Guillermo Villacampa19
- Elena Élez17
- Ana Vivancos14
- Jordi Rodón14
- Cristina Viaplana13
- Elena Garralda11
- Irene Braña10
- Justin Guinney10
- Roberta Fasani9
- Teresa Macarulla9
- Cristina Saura8
- Enriqueta Felip8
- Violeta Serra8
- José Jimenez7
- Marta Guzmán7
- Olga Rodríguez7
- Raquel Pérez-López7
- Aleix Prat6
- Ana Oaknin6
- David Tamborero6
- Guillem Argilés6
- Joaquı́n Mateo6
All papers
- The consensus molecular subtypes of colorectal cancer
Authors: Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laëtitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino, Brian M. Bot, Jeffrey S. Morris, Iris Simón, Sarah Gerster, Evelyn Fessler, Felipe de Sousa e Melo, Edoardo Missiaglia, Hena R. Ramay, David Barras, Krisztián Homicskó, Dipen Maru, Ganiraju C. Manyam, Bradley M. Broom, Valérie Boige, Beatriz Pérez‐Villamil, Ted Laderas, Ramón Salazar, Joe W. Gray, Douglas Hanahan, Josep Tabernero, René Bernards, Stephen Friend, Pierre Laurent‐Puig, Jan Paul Medema, Anguraj Sadanandam, Lodewyk F.A. Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar - Nature Medicine 2015 cited by 5,259
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
Authors: Fernanda Mosele, Jordi Remón, Joaquı́n Mateo, C. Benedikt Westphalen, Fabrice Barlési, Martijn P. Lolkema, Nicola Normanno, Aldo Scarpa, Mark E. Robson, Funda Meric‐Bernstam, Nikhil Wagle, Albrecht Stenzinger, Jean-François Bonastre, Ariane Bayle, Stefan Michiels, Ivan Bièche, Étienne Rouleau, S. Jezdic, J.-Y. Douillard, J.S. Reis-Filho, Rodrigo Dienstmann, Fabrice André - Annals of Oncology 2020 cited by 1,188
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Authors: Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann, S. Jezdic, Abel González-Pérez, Núria López-Bigas, Charlotte K.Y. Ng, Philippe L. Bédard, Giampaolo Tortora, J.-Y. Douillard, Eliezer M. Van Allen, Nikolaus Schultz, Charles Swanton, F. André, Lajos Pusztai - Annals of Oncology 2018 cited by 787
- Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Authors: Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, Scott Kopetz, Sabine Tejpar, Josep Tabernero - Nature reviews. Cancer 2017 cited by 1,030
- ESMO Guidance for Reporting Oncology real-World evidence (GROW)
Authors: Luís Castelo-Branco, Anna Pellat, Diogo Martins-Branco, Antonios Valachis, Jeroen W. G. Derksen, Karijn P.M. Suijkerbuijk, Urania Dafni, Tereza Dellaporta, Arndt Vogel, Arsela Prelaj, Rolf H. H. Groenwold, Henrique Martins, Rolf A. Stahel, Judith M. Bliss, Jakob Nikolas Kather, Nuria Ribelles, Francesco Perrone, Peter S Hall, Rodrigo Dienstmann, Christopher M. Booth, George Pentheroudakis, Suzette Delaloge, Miriam Koopman - Annals of Oncology 2023 cited by 210
- CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Authors: Malachi Griffith, Nicholas C. Spies, Kilannin Krysiak, Joshua F. McMichael, Adam Coffman, Arpad Danos, Benjamin J. Ainscough, Cody A. Ramirez, Damian Rieke, Lynzey Kujan, Erica K. Barnell, Alex H. Wagner, Zachary L. Skidmore, Amber Z. Wollam, Connor J. Liu, Martin Jones, Rachel L Bilski, Robert Lesurf, Yan-Yang Feng, Nakul M. Shah, Melika Bonakdar, Lee Trani, Matthew K. Matlock, Avinash Ramu, Katie M. Campbell, Gregory C. Spies, Aaron Graubert, Karthik Gangavarapu, James M. Eldred, David E. Larson, Jason Walker, Benjamin M. Good, Chunlei Wu, Andrew I. Su, Rodrigo Dienstmann, Adam A. Margolin, David Tamborero, Núria López-Bigas, Steven J.M. Jones, Ron Bose, David H. Spencer, Lukas D. Wartman, Richard K. Wilson, Elaine R. Mardis, Obi L. Griffith - Nature Genetics 2017 cited by 674
- A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Authors: Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir H. Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles‐Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, María Vidal, Vicente Peg, Xavier Serres, Graham Dellaire, Jacques Simard, Paolo Nucíforo, Isabel T. Rubio, Rodrigo Dienstmann, J. Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J. O’Connor, Orland Dı́ez, Judith Balmañà, Violeta Serra - EMBO Molecular Medicine 2018 cited by 274
- High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
Authors: Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel González-Pérez, Mafalda Oliveira, Fara Brasó‐Maristany, Nusaïbah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, María Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández‐Losa, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquı́n Arribas, Stefan Michiels, Alicia García‐Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nucíforo, Rodrigo Dienstmann, Chandra Verma, Núria López-Bigas, Maurizio Scaltriti, Mónica Arnedos, Cristina Saura, Violeta Serra - Nature Communications 2022 cited by 120
- Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis
Authors: Marta Ligero, Olivia Jordi-Ollero, Kinga Bernatowicz, Alonso García-Ruiz, Eric Delgado-Muñoz, David Leiva, Richard Mast, Cristina Suárez, Roser Sala‐Llonch, Nahum Calvo, Manuel Escobar, Arturo Navarro-Martín, Guillermo Villacampa, Rodrigo Dienstmann, Raquel Pérez-López - European Radiology 2020 cited by 205
- The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Authors: David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, Jorrit Boekel, Adrià López‐Fernández, Markus Jonsson, Ali Razzak, Irene Braña, Luigi De Petris, Jeffrey Yachnin, Richard D. Baird, Yohann Loriot, Christophe Massard, Patricia Martín-Romano, Frans L. Opdam, Richard F. Schlenk, Claudio Vernieri, Michele Masucci, Xenia Villalobos, Elena Chavarria, Shubha Anand, Danny Baars, Svetlana Bajalica‐Lagercrantz, Richard D. Baird, Mariska Bierkens, Lennart Blomqvist, Costanza Bono, Luigi De Petris, Gary J. Doherty, A Forest, Valentina Fornerone, Paola Gabaldi, Felix Haglund, Johan Hartman, Peter Horak, Tanja Jutzi, Mary Kasanicki, Simon Kreutzfeldt, Lucian Le Cornet, Rolf Lewensohn, Johan Lindberg, Carlos López, Andreas Lundqvist, Jose‐Ezequiel Martín, Gerrit A. Meijer, Susana Muñoz, Maud Ngo Camus, Claudio Nicotra, Paolo Nucíforo, Petra Oberrauch, Päivi Östling, Laura Pelz, Alejandro Piris‐Giménez, Elena Provenzano, Étienne Rouleau, John Rowell, Omar Saavedra, Giovanni Scoazec, Kenneth B. Seamon, Marc Tischkowitz, Lizet van der Kolk, Ruud van der Noll, María Vieito, Daniël J. Vis, Ana Vivancos, Christina von Gertten, Anders Wennborg, Lodewyk F.A. Wessels, Valtteri Wirta, Judith Balmañà, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E. Voest, Jordi Rodón, Janne Lehtiö - Nature Cancer 2022 cited by 130
- RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
Authors: Elena Élez, Javier Ros, J. Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, R. Comas, Shanshan Li, David P. Kodack, Roberta Fasani, Ariadna García, Javier Gonzalo‐Ruiz, Alejandro Piris‐Giménez, Paolo Nucíforo, Gráinne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Pérez-López, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A. Toledo - Nature Medicine 2022 cited by 111
- Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer
Authors: Garazi Serna, Fiorella Ruíz‐Pace, Jorge Hernando, Lidia Alonso, Roberta Fasani, Stefania Landolfi, R. Comas, José Jimenez, Elena Élez, Susan Bullman, Josep Tabernero, Jaume Capdevila, Rodrigo Dienstmann, Paolo Nucíforo - Annals of Oncology 2020 cited by 150
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
Authors: Rodrigo Dienstmann, Jordi Rodón, Aleix Prat, José Manuel Pérez-García, Bárbara Adamo, Enriqueta Felip, Javier Cortés, A. John Iafrate, Paolo Nucíforo, Josep Tabernero - Annals of Oncology 2013 cited by 366
- Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
Authors: Clara Montagut, Guillem Argilés, Fortunato Ciardiello, Thomas T. Poulsen, Rodrigo Dienstmann, Michael Kragh, Scott Kopetz, Trine Lindsted, Cliff Ding, Joana Vidal, Jenifer Clausell-Tormos, Giulia Siravegna, Francisco Javier Sánchez-Martín, Klaus Koefoed, Mikkel W. Pedersen, Michael M. Grandal, Mikhail Dvorkin, Lucjan Wyrwicz, Ana Rovira, Antonio Cubillo, Ramón Salazar, Françoise Desseigne, Cristina Nadal, Joan Albanell, Vittorina Zagonel, Salvatore Siena, Guglielmo Fumi, Giuseppe Rospo, Paul I. Nadler, Ivan D. Horak, Alberto Bardelli, Josep Tabernero - JAMA Oncology 2018 cited by 144
- A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
Authors: David Tamborero, Carlota Rubio-Pérez, Ferran Muiños, Radhakrishnan Sabarinathan, Josep M. Piulats, Aura Muntasell, Rodrigo Dienstmann, Núria López-Bigas, Abel González-Pérez - Clinical Cancer Research 2018 cited by 422
- Development of PI3K inhibitors: lessons learned from early clinical trials
Authors: Jordi Rodón, Rodrigo Dienstmann, Violeta Serra, Josep Tabernero - Nature Reviews Clinical Oncology 2013 cited by 766
- Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Authors: Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop‐Guevara, Flaminia Pedretti, Alejandro Moles‐Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso, José Jimenez, Enrique J. Arenas, Andrea Degasperi, João M.L. Dias, Josep V. Forment, Mark J. O’Connor, Olivier Déas, Stefano Cairo, Yinghui Zhou, Antonino Musolino, Carlos Caldas, Serena Nik‐Zainal, Robert B. Clarke, Paolo Nucíforo, Orland Dı́ez, Xavier Serres, Vicente Peg, Martín Espinosa-Bravo, Teresa Macarulla, Ana Oaknin, Joaquı́n Mateo, Joaquı́n Arribas, Rodrigo Dienstmann, Meritxell Bellet, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez‐Enríquez, Judith Balmañà, Violeta Serra - Cancer Research 2022 cited by 97
- Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
Authors: Rodrigo Dienstmann, Jordi Rodón, Violeta Serra, Josep Tabernero - Molecular Cancer Therapeutics 2014 cited by 465
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
Authors: Rodrigo Dienstmann, Guillermo Villacampa, Anita Sveen, Mike J. Mason, Donna Niedzwiecki, Arild Nesbakken, Vı́ctor Moreno, Robert S. Warren, Ragnhild A. Lothe, Justin Guinney - Annals of Oncology 2019 cited by 266
- A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
Authors: Marta Ligero, Alonso García-Ruiz, Cristina Viaplana, Guillermo Villacampa, Maria Vittoria Raciti, Jaid Landa, Ignacio Matos, Juan Martín-Liberal, María Ochoa-de-Olza, Cinta Hierro, Joaquı́n Mateo, Macarena González, Rafael Morales‐Barrera, Cristina Suárez, Jordi Rodón, Elena Élez, Irene Braña, Eva Muñoz‐Couselo, Ana Oaknin, Roberta Fasani, Paolo Nucíforo, Débora Gil, Carlota Rubio-Pérez, Joan Seoane, Enriqueta Felip, Manuel Escobar, Josep Tabernero, Joan Carles, Rodrigo Dienstmann, Elena Garralda, Raquel Pérez-López - Radiology 2021 cited by 105
- Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
Authors: Alba Llop‐Guevara, Sibylle Loibl, Guillermo Villacampa, Valentina Vladimirova, Andreas Schneeweiß, Thomas Karn, D-M. Zahm, Andrea Herencia-Ropero, Paul Jank, Marion van Mackelenbergh, Peter A. Fasching, Frederik Marmé, Elmar Stickeler, Christian Schem, Rodrigo Dienstmann, Stefan Florian, Valentina Nekljudova, Judith Balmañà, E. Hahnen, Carsten Denkert, Violeta Serra - Annals of Oncology 2021 cited by 101
- Early-Stage Breast Cancer Detection in Breast Milk
Authors: Cristina Saura, Carolina Ortiz, Judit Matito, Enrique J. Arenas, Anna Suñol, Ágatha Martín, Octavi Córdoba, Alex Martínez-Sabadell, Itziar García-Ruiz, Ignacio Miranda, Clara Morales-Comas, Estela Carrasco, Cristina Viaplana, Vicente Peg, Paolo Nucíforo, Neus Bayó-Puxan, Alberto González‐Medina, Josep M. Miquel, Marina Gómez-Rey, Guillermo Villacampa, Sílvia Arévalo, Martín Espinosa-Bravo, Judith Balmañà, Rodrigo Dienstmann, Joaquı́n Arribas, Josep Tabernero, Ana Vivancos, Miriam Sansó - Cancer Discovery 2023 cited by 58
- A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Authors: Alex H. Wagner, Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak, Jordi Deu-Pons, Ryan P. Duren, Jianjiong Gao, Julie A. McMurry, Sara E. Patterson, Catherine Del Vecchio Fitz, Beth A. Pitel, Ozman U. Sezerman, Kyle Ellrott, Jeremy L. Warner, Damian Rieke, Tero Aittokallio, Ethan Cerami, Deborah Ritter, Lynn M. Schriml, Robert R. Freimuth, Melissa Haendel, Gordana Raca, Subha Madhavan, Michael Baudis, J. Beckmann, Rodrigo Dienstmann, Debyani Chakravarty, Xuan Shirley Li, Susan M. Mockus, Olivier Elemento, Nikolaus Schultz, Núria López-Bigas, Mark Lawler, Jeremy Goecks, Malachi Griffith, Obi L. Griffith, Adam A. Margolin - Nature Genetics 2020 cited by 176
- ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma
Authors: Helena Verdaguer, Tamara Saurí, Daniel Alejandro Acosta, Magdalena Guardiola, Alexandre Sierra, Jorge Hernando, Paulo Nuciforo, Josep M. Miquel, Cristina Molero, Sandra Peiró, Queralt Serra-Camprubí, Guillermo Villacampa, Susana Aguilar, Ana Vivancos, Josep Tabernero, Rodrigo Dienstmann, Teresa Macarulla - Clinical Cancer Research 2022 cited by 65
